165 related articles for article (PubMed ID: 25696014)
21. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
22. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
23. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.
Van Loo P; Tousseyn T; Vanhentenrijk V; Dierickx D; Malecka A; Vanden Bempt I; Verhoef G; Delabie J; Marynen P; Matthys P; De Wolf-Peeters C
Haematologica; 2010 Mar; 95(3):440-8. PubMed ID: 19797726
[TBL] [Abstract][Full Text] [Related]
24. T-cell/histiocyte-rich B cell lymphoma mimicking Hodgkin's lymphoma.
Majhi U; Shirley S; Murhekar KM
Indian J Cancer; 2010; 47(1):70-2. PubMed ID: 20071794
[No Abstract] [Full Text] [Related]
25. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
Glynn E; Fromm JR
Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
[TBL] [Abstract][Full Text] [Related]
26. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Hartmann S; Cogliatti S; Hansmann ML
Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
[TBL] [Abstract][Full Text] [Related]
27. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.
Hartmann S; Eichenauer DA
Pathology; 2020 Jan; 52(1):142-153. PubMed ID: 31785822
[TBL] [Abstract][Full Text] [Related]
28. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
Prakash S; Fountaine T; Raffeld M; Jaffe ES; Pittaluga S
Am J Surg Pathol; 2006 May; 30(5):585-92. PubMed ID: 16699312
[TBL] [Abstract][Full Text] [Related]
29. Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.
Cano I; Lozano M; Rodríguez A; Mate A; Adrados M; López Mdel M; Carro R; Montes-Moreno S
Histopathology; 2010 Jul; 57(1):159-62. PubMed ID: 20653789
[No Abstract] [Full Text] [Related]
30. [T cell/histiocyte-rich large B cell lymphoma].
Liu DG; Du J; Yu Q
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):377-8. PubMed ID: 16185515
[No Abstract] [Full Text] [Related]
31. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
[TBL] [Abstract][Full Text] [Related]
32. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
33. Primary T cell/histiocyte-rich large B-cell lymphoma of the orbit.
Kim UR; Shah AD; Shanti R; Arora V
Ophthalmic Plast Reconstr Surg; 2011; 27(2):e31-2. PubMed ID: 20562665
[TBL] [Abstract][Full Text] [Related]
34. A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide.
Siricilla M; Irwin L; Ferber A
Case Rep Oncol Med; 2018; 2018():6137454. PubMed ID: 29552367
[TBL] [Abstract][Full Text] [Related]
35. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia.
Kunder C; Cascio MJ; Bakke A; Venkataraman G; O'Malley DP; Ohgami RS
Am J Clin Pathol; 2017 Jun; 147(6):596-603. PubMed ID: 28575178
[TBL] [Abstract][Full Text] [Related]
36. 'T-cell-rich large B-cell lymphoma'-'histiocyte-rich, T-cell-rich large B-cell lymphoma'-'T-cell/histiocyte-rich large B-cell lymphoma': will we ever see the wood for the trees?
De Wolf-Peeters C; Achten R
Histopathology; 2002 Sep; 41(3):269-71. PubMed ID: 12207791
[No Abstract] [Full Text] [Related]
37. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.
Abramson JS
Oncologist; 2006 Apr; 11(4):384-92. PubMed ID: 16614234
[TBL] [Abstract][Full Text] [Related]
38. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
39. A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes.
Oyaizu N; Kozai Y; Kodo H; Sunaga S; Iwabuchi K; Higashihara M; Mori S
Acta Haematol; 2005; 113(3):194-7. PubMed ID: 15870490
[TBL] [Abstract][Full Text] [Related]
40. A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma.
Ally F; Gajzer D; Fromm JR
Clin Lab Med; 2023 Sep; 43(3):427-444. PubMed ID: 37481321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
